Subsequent studies confirmed the presence of SPAG16-specific oligoclonal bands in the CSF of some MS patients (5 of 23), as well as elevated anti-SPAG16 antibody titers in serum relative to controls [93]. This evidence concerns the gene SPAG16 and myeloid sarcoma.